The next ProteoCure Targeted Protein Degradation seminar organised by the WG3 will be on Thursday 20th April 13:00 h (CET time).
The speaker of this seminar will be Matthias Brand (CSO at Proxygen, https://proxygen.com).
Please log in to see the link for this webinar.
*******************
“Harnessing the power of phenotypic screening for glue degrader discovery”
Matthias Brand studied medical and molecular biotechnology in Milan (Italy). For his PhD, he joined the group of Georg Winter at CeMM in 2016, where he specialised on targeted protein degradation via small molecules. In particular, he worked on means to engineer selectivity into PROTACs and resistance mechanisms to this novel pharmacology. He furthermore contributed to the development of screening assays for the scalable identification of novel E3 modulators. Since 2020, he is VP Biology and co-founder of Proxygen, a biotech startup dedicated to the discovery and development of novel molecular.
*******************